CD8B2 is a member of the CD8 beta gene family involved in T cell biology. As part of the CD8 heterodimer with CD8 alpha, CD8B2 identifies cytotoxic and suppressor T cells that recognize MHC class I-bearing targets and is thought to play a role in T cell-mediated killing. The human CD8 beta locus exists as a duplication, with CD8B2 containing six exons that undergo alternative splicing to produce multiple transcript isoforms 1. These isoforms show differential expression in thymus and peripheral tissues, with some encoding membrane-spanning proteins capable of forming heterodimers with CD8 alpha, while others lack transmembrane regions and may be secreted 1. In disease contexts, CD8B2 has emerged as a prognostic biomarker in ovarian cancer, where it was identified as one of five cuproptosis-related genes in a predictive model stratifying patients by survival risk 2. Additionally, CD8B2 was identified as a differentially expressed adaptive immune response gene in Parkinson's disease, suggesting its involvement in immune dysfunction associated with neurodegeneration 3. These findings indicate CD8B2's significance extends beyond canonical CD8+ T cell function to include broader roles in immune-mediated disease pathogenesis.